EXAS Latest Press Releases

-- January 21, 2026 --

Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 4:52 PM

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS PRNewswire 3:58 PM

-- January 17, 2026 --

Halper Sadeh LLC Encourages SEE, EXAS, ZEUS Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 12:56 PM

-- January 16, 2026 --

Exact Sciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS PRNewswire 2:02 PM

-- January 9, 2026 --

Halper Sadeh LLC Encourages EXAS, FRGE, TBHC, FFWM Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 2:11 PM

-- January 8, 2026 --

Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026 Business Wire 4:30 PM

Halper Sadeh LLC Encourages FRGE, EXAS, CIVI, KVUE Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 12:48 PM

-- January 6, 2026 --

Halper Sadeh LLC Encourages EXAS, SOAR, BTBD Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 11:00 AM

-- December 30, 2025 --

Exact Sciences Shareholders Unhappy With $105 Per Share Sale to Abbott Should Contact Julie & Holleman LLP Regarding Potential Claims Globe Newswire 9:31 AM

-- December 11, 2025 --

Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect MRD Test in Early Triple-Negative Breast Cancer at SABCS Business Wire 5:30 PM

-- November 28, 2025 --

Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 12:41 PM

-- November 27, 2025 --

HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN PRNewswire 11:11 PM

Halper Sadeh LLC Encourages SEE, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 6:48 PM

-- November 25, 2025 --

Halper Sadeh LLC Encourages GDOT, BLFY, EXAS Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 1:33 AM

-- November 24, 2025 --

Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium Business Wire 4:35 PM

EXAS Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Exact Sciences to Abbott Laboratories Globe Newswire 9:30 AM

-- November 22, 2025 --

Halper Sadeh LLC Encourages EXAS, NVRI, MRUS Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 6:25 AM

-- November 21, 2025 --

Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS Business Wire 8:30 PM

-- November 20, 2025 --

Halper Sadeh LLC Encourages CIVI, JAMF, EXAS Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 7:50 PM

Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth Business Wire 4:15 PM

Shareholder Alert: The Ademi Firm investigates whether Exact Sciences Corporation is obtaining a Fair Price for its Public Shareholders PRNewswire 11:45 AM

EXAS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Exact Sciences Corporation is Fair to Shareholders Business Wire 9:03 AM

Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments PRNewswire 7:30 AM

-- November 10, 2025 --

Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome's Blood-Based Colorectal Cancer Screening Tests Business Wire 7:00 AM

-- November 7, 2025 --

Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test Business Wire 8:00 AM

-- November 4, 2025 --

Exact Sciences to Participate in November Investor Conference Business Wire 7:00 AM

-- November 3, 2025 --

Exact Sciences Announces Third Quarter 2025 Results Business Wire 4:05 PM

-- October 27, 2025 --

Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps Business Wire 7:00 AM

-- October 16, 2025 --

4 Diagnostic Stocks Targeting 25%+ Annual Growth in a $20B Market (MDCX, ILMN, EXAS, GH) AB Digital Inc 4:12 PM

-- October 8, 2025 --

Exact Sciences Schedules Third Quarter 2025 Earnings Call Business Wire 7:00 AM

-- October 7, 2025 --

New Study in Journal of the National Cancer Institute Finds Cologuard Plus Provides the Most Life-Years Gained with the Fewest Colonoscopies Business Wire 6:59 AM

-- September 22, 2025 --

Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard Test Business Wire 7:00 AM

-- September 10, 2025 --

Exact Sciences Launches Cancerguard , First-of-Its-Kind Multi-Cancer Early Detection Blood Test Business Wire 6:30 AM